Understanding characteristics associated with discontinuation of biologic therapy in patients with severe asthma is necessary to help to address barriers to treatment success in this population. Which of the following is the most commonly reported barrier to biologic adherence?
Patients who are already taking an osteoporosis medication should repeat their bone density test by central dual-energy x-ray absorptiometry (DXA) every 1 to 2 years, according to the NOF.
For more quizzes, visit the Osteoporosis Quiz Challenge Microsite.